Exhaled matrix metalloproteinase-9 (MMP-9) in different biological phenotypes of asthma

European Journal of Internal Medicine

Volumn 25, Issue 1, 2014, Pages 92-96

  Barbaro, Maria P Foschino ^a   Spanevello, Antonio ^b,c   Palladino, Grazia P ^a   Salerno, Francesco G ^c   Lacedonia, Donato ^a   Carpagnano, Giovanna E ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c IRCCS   (Italy)

Author keywords

Airways; Asthma; MMP 9; Non invasive methods; Phenotype

Indexed keywords

GELATINASE B; NITRIC OXIDE;

ADULT; AIRWAY REMODELING; ARTICLE; ASTHMA; CONTROLLED STUDY; EXHALATION; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATORY CELL; MAJOR CLINICAL STUDY; NEUTROPHIL; PH; PHENOTYPE; RESPIRATORY TRACT INFLAMMATION; SPUTUM ANALYSIS;

AIRWAY SMOOTH MUSCLE; AIRWAYS; ASM; ASTHMA; BAL; BRONCHO-ALVEOLARE LAVAGE; FEV(1); FORCED EXPIRATORY VOLUME IN ONE SECOND; FORCED VITAL CAPACITY; FVC; MATRIX METALLOPROTEINASE-9; MMP-9; NITRIC OXIDE; NO; NON-INVASIVE METHODS; PHENOTYPE; TIMPS; TISSUE INHIBITORS OF METALLOPROTEINASES;

ADULT; ASTHMA; BIOLOGICAL MARKERS; BREATH TESTS; CASE-CONTROL STUDIES; EOSINOPHILIA; EOSINOPHILS; FORCED EXPIRATORY VOLUME; HUMANS; HYDROGEN-ION CONCENTRATION; INFLAMMATION; MATRIX METALLOPROTEINASE 9; NEUTROPHILS; NITRIC OXIDE; PHENOTYPE; SEVERITY OF ILLNESS INDEX; SPUTUM;

EID: 84892804854     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2013.08.705     Document Type: Article

References (36)

1. Global Initiative for Asthma (GINA), and National Heart, Lung and Blood Institute (NHLBI) Global strategy for asthma management and prevention 2006 Global Initiative for Asthma (GINA), National Heart, Lung and Blood Institute (NHLBI) Bethesda (MD) 339
2. R. Beasley, W. Roche, and S.T. Holgate Inflammatory processes in bronchial asthma Drugs 37 1989 117 122
3. J.P. Bousquet, J.Y. Chanez, R. Lacoste, P. White, Vic, and P. Godard et al. Asthma: a disease remodeling the airways Allergy 47 1992 3 11
4. P.T. Macklem A theoretical analysis of the effect of airway smooth muscle load on airway narrowing Am J Respir Crit Care Med 153 1996 83 89
5. F.G. Salerno, V. Pinelli, L. Pini, B. Tuma, R.V. Iozzo, and M.S. Ludwig Effect of PEEP on induced constriction is enhanced in decorin-deficient mice Am J Physiol Lung Cell Mol Physiol 293 2007 L1111 L1117
6. L. Pini, Q. Hamid, J. Shannon, L. Lemelin, R. Olivenstein, and P. Ernst et al. Differences in proteoglycan deposition in the airways of moderate and severe asthmatics Eur Respir J 29 2007 71 77
7. P. Borger, M. Tamm, J.L. Black, and M. Roth Asthma: is it due to an abnormal airway smooth muscle cell? Am J Respir Crit Care Med 174 2006 367 372
8. S.S. An, T.R. Sai, and J.H. Bates et al. Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma Eur Respir J 29 2007 834 860
9. B.B. Araujo, M. Dolhnikoff, L.F.F. Silva, J. Elliot, J.H.N. Lindeman, and D.S. Ferreira et al. Extracellular matrix components and regulators in the airway smooth muscle in asthma Eur Respir J 32 2008 61 69
10. K.J. Greenle, Z. Werb, and F. Kheradmand Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted Physiol Rev 87 2007 69 98
11. Yc Lee, and H.K. Lee Vascular endothelial growth factor in patients with acute asthma J Allergy Clin Immunol 107 2001 1106
12. A.M. Vignola, L. Riccobono, A. Mirabella, M. Profita, P. Chavez, and V. Bellia et al. Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis Am J Respir Crit Care Med 158 1998 1945 1950
13. J.L. Simpson, R.J. Scott, M.J. Boyle, and P.G. Gibson Differential proteolytic enzyme activity in eosinophilic and neutrophilic asthma Am J Respir Crit Care Med 172 2005 559 565
14. M. Vignola, F. Paganin, L. Capieu, N. Scichilone, M. Bellia, and L. Maakel et al. Airway remodeling assessed by sputum and high resolution computed tomography in asthma and COPD Eur Respir J 24 2004 910 917
15. L.A. Laitinen, M. Heino, and A. Laitinen et al. Damage of the airway epithelium and bronchial reactivity in patient with asthma Am Rev Respir Dis 131 1985 599 606
16. A.E. Redigton, P.J. Sime, and P.H. Howarth et al. Fibroblasts and the extracellular matrix in asthma G. Marone, K.F. Austen, S.T. Holgate, Asthma in allergic diseases: physiology, immunopharmacology, and treatment 1998 Academic Press London, UK 443 467
17. I. Ohno, H. Ohtani, and Y. Nitta et al. Eosinophils as source of matrix metalloproteinase-9 in asthmatic airway inflammation Am J Respir Cell Mol Biol 16 1997 212 219
18. W. Mattos, S. Lim, R. Russell, A. Jatakanon, K.F. Chung, and P.J. Barnes Matrix metalloproteinase-9 expression in asthma Chest 122 2002 1543 1552
19. C. Bergeron, M.K. Tulic, and Q. Hamid Tools used to measure airway remodeling in research Eur Respir J 29 2007 596 604
20. The ENFUMOSA Study Group The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma Eur Respir J 22 2003 470 477
21. M. Bossè, J. Chakir, M. Rouabhia, L.F. Boulet, M. Audette, and M. Laviolette Serum matrix metalloproteinase-9: tissue inhibitor of metalloproteinase-1 ratio correlates with steroid responsiveness in moderate to severe asthma Am J Respir Crit Care Med 159 1999 596 602
22. G. Mautino, N. Oliver, and P. Chavez et al. Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatic Am J Respir Cell Mol Biol 17 1997 583 591
23. C.M. O'Connor, and M.X. FitzGerald Matrix metalloproteinases and lung disease Thorax 49 1994 602 609
24. G.E. Carpagnano, P.J. Barnes, J. Francis, N. Wilson, A. Bush, and S.A. Kharitonov Breath condensate pH in children with cystic fibrosis and asthma: a new noninvasive marker of airway inflammation? Chest 125 2004 2005 2010
25. From the global strategy for asthma management and prevention 2012 Global Initiative for Asthma (GINA) [Available from: http://www.ginasthma.org/ ]
26. S. Dreborg Skin testing. The safety of skin tests and the information obtained from using different methods and concentrations of allergen Allergy 48 1993 473 475
27. J.M. Bland, and D.G. Altman Measuring agreement in method comparison studies Stat Methods Med Res 8 1999 135 160
28. L. Liu, P. Urban, J.F. Hunt, P. Wilkinson, K. Laning, and B. Gaston Changes in exhaled nitric oxide and breath pH during fluticasone wean in asthma Respiration 79 2010 193 199
29. Z. Borrill, C. Starkey, J. Vestbo, and D. Singh Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease Eur Respir J 25 2005 269 274
30. American Thoracic Society; European Respiratory Society ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005 Am J Respir Crit Care Med 171 2005 912 930
31. S.A. Kharitonov, F. Gonio, C. Kelly, S. Meah, and P.J. Barnes Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children Eur Respir J 21 2003 433 438
32. A. Spanevello, M. Gonfalonieri, and F. Sulotto et al. Induced sputum cellularity Am J Respir Crit Care Med 162 2000 1172 1174
33. R. Suzuki, T. Kato, Y. Miyazaki, M. Iwata, Y. Noda, and K. Takagi et al. Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in sputum from patients with bronchial asthma J Asthma 38 2001 477 484
34. S.E. Wenzel, S. Balzar, M. Cundall, and H.W. Chu Sup epithelial basement membrane immunoreactivity for matrix metalloproteinase 9: association with asthma severity, neutrophilic inflammation and wound repair J Allergy Clin Immunol 111 2003 1345 1352
35. M. Cundall, Y. Sun, C. Miranda, J.B. Trudeau, S. Barnes, and S.E. Wenzel Neutrophil-derived matrix metalloproteinase-9 is increased in severe asthma and poorly inhibited by glucocorticoids J Allergy Clin Immunol 112 2003 1064 1071
36. G.B. Karakoc, A. Inal, M. Yilmaz, D.U. Altintas, and S.G. Kendirli Exhaled breath condensate MMP-9 levels in children with bronchiectasis Pediatr Pulmonol 44 2009 1010 1016